Loss of PINK1 Increases the Heart's Vulnerability to Ischemia-Reperfusion Injury. by Siddall, HK et al.
Loss of PINK1 Increases the Heart’s Vulnerability to
Ischemia-Reperfusion Injury
Hilary K. Siddall1, Derek M. Yellon1, Sang-Bing Ong2, Uma A. Mukherjee1, Niall Burke1, Andrew R. Hall1,
Plamena R. Angelova3, Marthe H. R. Ludtmann3, Emma Deas3, Sean M. Davidson1, Mihaela M. Mocanu1,
Derek J. Hausenloy1*
1 The Hatter Cardiovascular Institute, University College London, London, United Kingdom, 2Department of Clinical Sciences, Faculty of Biosciences and Medical
Engineering, Universiti Teknologi Malaysia, Johor Bahru, Malaysia, 3Department of Molecular Neuroscience, University College London Institute of Neurology, London,
United Kingdom
Abstract
Objectives: Mutations in PTEN inducible kinase-1 (PINK1) induce mitochondrial dysfunction in dopaminergic neurons
resulting in an inherited form of Parkinson’s disease. Although PINK1 is present in the heart its exact role there is unclear. We
hypothesized that PINK1 protects the heart against acute ischemia reperfusion injury (IRI) by preventing mitochondrial
dysfunction.
Methods and Results: Over-expressing PINK1 in HL-1 cardiac cells reduced cell death following simulated IRI (29.265.2%
PINK1 versus 49.062.4% control; N = 320 cells/group P,0.05), and delayed the onset of mitochondrial permeability
transition pore (MPTP) opening (by 1.3 fold; P,0.05). Hearts excised from PINK1+/+, PINK1+/2 and PINK12/2 mice were
subjected to 35 minutes regional ischemia followed by 30 minutes reperfusion. Interestingly, myocardial infarct size was
increased in PINK12/2 hearts compared to PINK1+/+ hearts with an intermediate infarct size in PINK1+/2 hearts
(25.162.0% PINK1+/+, 38.963.4% PINK1+/2 versus 51.564.3% PINK12/2 hearts; N.5 animals/group; P,0.05).
Cardiomyocytes isolated from PINK12/2 hearts had a lower resting mitochondrial membrane potential, had inhibited
mitochondrial respiration, generated more oxidative stress during simulated IRI, and underwent rigor contracture more
rapidly in response to an uncoupler when compared to PINK1+/+ cells suggesting mitochondrial dysfunction in hearts
deficient in PINK1.
Conclusions: We show that the loss of PINK1 increases the heart’s vulnerability to ischemia-reperfusion injury. This may be
due, in part, to increased mitochondrial dysfunction. These findings implicate PINK1 as a novel target for cardioprotection.
Citation: Siddall HK, Yellon DM, Ong S-B, Mukherjee UA, Burke N, et al. (2013) Loss of PINK1 Increases the Heart’s Vulnerability to Ischemia-Reperfusion
Injury. PLoS ONE 8(4): e62400. doi:10.1371/journal.pone.0062400
Editor: Rakesh Kukreja, Virginia Commonwealth University Medical Center, United States of America
Received September 28, 2012; Accepted March 21, 2013; Published April 29, 2013
Copyright:  2013 Siddall et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the British Heart Foundation grant number FS/06/023 and supported by researchers at the National Institute for Health
Research University College London Hospitals Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to
publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: d.hausenloy@ucl.ac.uk
Introduction
Mitochondria perform a dual role in the life and death of the
cardiomyocyte. When functioning normally they generate the
energy required for normal cellular processes and survival.
However, in situations of cellular stress such as during acute
myocardial ischemia-reperfusion injury (IRI), they can become
dysfunctional and be the arbitrators of cardiomyocyte death.
Therefore, new treatment strategies which are capable of
preventing mitochondrial dysfunction during acute IRI may
reduce myocardial injury, preserve cardiac function and improve
clinical outcomes in patients with ischemic heart disease.
In this regard, the mitochondrial serine-threonine protein
kinase, PTEN (phosphatase and tensin homologue on chromo-
some 10)-induced kinase 1 (PINK1), may provide a novel
therapeutic target for cardioprotection [1]. Mutations in the
PINK1 gene are responsible for the autosomal recessive PARK6
inherited form of early onset Parkinson disease, a neurodegener-
ative disorder characterized by the loss of dopaminergic neurons
in the substantia nigra [2]. Genetic ablation of PINK1 in neurons
results in mitochondrial dysfunction characterized by: mitochon-
drial membrane depolarization [3,4], reduced mitochondrial
respiration and ATP levels [5], increased oxidative stress [3,4,6–
9], mitochondrial calcium overload [4], and enhanced suscepti-
bility to mitochondrial permeability transition pore (MPTP)
opening [4]. In contrast, wild-type PINK1 has been reported to
protect neurons from mitochondrial dysfunction [2], reduce
mitochondrial cytochrome C release and caspase 3 and 9
activation [10,11], and attenuate apoptotic cell death [2,10].
Interestingly, PINK1 protein is highly expressed in the
myocardium [12] but its role in the heart, is not clear [1,13].
Given its beneficial effects on mitochondrial function and
neuroprotective properties, we investigated whether PINK1 could
also protect the heart against acute IRI. We find that the loss of
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PINK1 increases the heart’s vulnerability to ischemia-reperfusion
injury and this may be by worsening mitochondrial function.
Materials and Methods
Animal experiments were conducted in strict accordance with
the Animals (Scientific Procedures) Act 1986 published by the UK
Home Office and the Guide for the Care and Use of Laboratory Animals
published by the US National Institutes of Health (NIH
Publication No. 85–23, revised 1996). Approval has been granted
by a local ethics review board at University College London. All
efforts were made to minimize suffering.
HL-1 Cell Culture and PINK1 Over-expression
HL-1 cells are an adherent murine atrial cell line that
spontaneously beat in culture (the cells were obtained from
Claycomb) [14]. Cells were cultured in tissue culture flasks pre-
coated for 2–3 hrs with 10 mg/ml fibronectin (diluted in 0.02%
gelatin). Growth medium (Claycomb media supplemented with
10% FBS, 2 mM L glutamine (Invitrogen, Gibco), 0.1 mM
norepinephrine (prepared in 30 mM ascorbic acid), 500 IU
penicillin and 500 mg streptomycin (PAA Laboratories)) was
changed every 1–2 days and cells were maintained at 37uC in
95%O2/5%CO2 with 90% humidity.
A similar vector expressing PINK1 under the control of the
CMV promoter (Addgene plasmid 13315: pcDNA-DEST53
PINK1) from Addgene Inc., Cambridge, MA was used to over-
express PINK1. HL-1 cells were seeded onto fibronectin coated
glass cover slips and upon reaching 50–60% confluence were
transfected for 24 hours using Fugene6 H (Roche, UK) according
to manufacturer’s instructions. The pEGFP expression plasmid
(Clontech) was included for identification of successfully trans-
fected cells, at a ratio of 1:2. The vector control group was
designated as cells transfected with an empty plasmid expression
vector (RcCMV). A similar vector expressing PINK1 under the
control of the CMV promoter (Addgene plasmid 13315: pcDNA-
DEST53 PINK1) from Addgene Inc., Cambridge, MA was used
to over-express PINK1 in a separate set of cells. The pEGFP
expression plasmid (Clontech) was included for identification of
successfully transfected cells, at a ratio of 1:2. The transfection
efficacy was 60–70% of cells. Culture media containing trans-
fection components was replaced with fresh growth medium and
cells were incubated overnight. Unfortunately due to a lack of
a specific commercially available PINK1 antibody were not able to
demonstrate PINK1 protein expression or localization.
Simulated Ischemia-reperfusion Injury in HL-1 Cells Over-
expressing PINK1
In order to determine the effect of PINK1 over-expression on
the susceptibility to simulated ischemia-reperfusion injury (SIRI),
HL-1 cells were subjected to a sustained episode of lethal hypoxia
and reoxygenation [15,16]. Culture medium was removed and
replaced with hypoxic buffer (comprising in mM: KH2PO4 1.0,
NaHCO3 10.0, MgCl2.6H2O 1.2, NaHEPES 25.0, NaCl 74.0,
KCl 16, CaCl2 1.2 and NaLactate 20 at pH 6.2, bubbled with
100% nitrogen) and then placed in an airtight custom-built
hypoxic chamber kept at 37uC for 12 hours to simulate ischemia.
Following the period of simulated ischemia, the cells were
removed from the hypoxic chamber and placed in normoxic
Claycomb medium (containing 3 mM propidium iodide) and
returned to a tissue culture incubator, to simulate reperfusion.
Following 1 hour simulated reperfusion at 37uC, the percentage of
GFP-transfected cells stained with propidium iodide was de-
termined using a Nikon Eclipse TE200 fluorescent microscope in
order to calculate the percentage cell death in each treatment
group. For each treatment group 80 cells were counted, taken
from four randomly-selected fields of view. This experiment was
repeated on at least four separate occasions giving a total of 320
cells per treatment group. For a time-matched normoxic control
group, HL-1 cells were placed in normoxic buffer (comprising in
mM: KH2PO4 1.0, NaHCO3 10.0, MgCl2.6H2O 1.2, NaHEPES
25.0, NaCl 98.0, KCl 3, CaCl2 1.2, d-glucose 10.0, Na pyruvate
2.0 at pH 7.4, bubbled with 5% CO2/95% O2) for the total 13
hours duration of the experiment and the percentage cell death
was determined.
ROS-induced MPTP Opening in HL-1 Cells Over-
expressing PINK1
To determine the effect of PINK1 over-expression on the
susceptibility to MPTP opening, a previously validated cell model
of MPTP opening was utilized [17]. Confocal laser-stimulation of
the fluorophore tetra methyl rhodamine methyl (TMRM), which
accumulates into mitochondria, generates reactive oxygen species
(ROS) within mitochondria. This cell model can be used to
simulate the events occurring at reperfusion, in which the
production of ROS results in MPTP opening and the collapse of
the mitochondrial membrane potential [17,18]. The collapse of
mitochondrial membrane potential in this cell model has pre-
viously been verified as indicating MPTP opening as it coincides
with the redistribution of calcein from the mitochondria to the
cytosol [19].
Culture medium was removed and replaced with Krebs imaging
buffer. Cells were then loaded with the 3 mM TMRM for 15 min
at 37uC and washed with Krebs imaging buffer. The time taken to
induce mitochondrial membrane depolarization is recorded as
a measure of susceptibility to MPTP opening. This was defined as
the time taken to reach half the maximum TMRM fluorescence
intensity. Twenty transfected cells were randomly selected for the
induction and detection of MPTP opening from each treatment
group, and this was repeated in four independent experiments
giving a total of 80 cells per treatment group. As a positive control
and in order to confirm that mitochondrial membrane de-
polarization was indicative of MPTP opening, following TMRM
loading, a group of cells were pre-treated for 10 minutes with the
MPTP inhibitor, cyclosporin A (0.2 mM) [15,20,21]. The time
taken to induce to MPTP opening was recorded.
HL-1 cells were visualized using a Leica TCS SP5 CLSM
confocal microscope equipped with HCX PL APO 406/1.25 oil
objective lens using the 488-nm of an Argon laser and the 543-nm
emission line of a HeNe laser. Time scans were recorded with
simultaneous excitation at 488 nm (for GFP) and 543 nm (for
TMRM), collecting fluorescence emission at 500–536 nm and
585–680 nm, respectively. For these MPTP experiments, all
conditions of the confocal imaging system (laser power, confocal
pinhole - set to give an optical slice of 1 micron – pixel dwell time,
and detector sensitivity) were identical to ensure comparability
between experiments. Images were analyzed using the LAS AF
Version: 2.0.0 Build 1934 software program.
PINK1 Knockout Mice
PINK1 knockout mice were a kind gift from Dr Luis Miguel
Martins and Dr Nicoleta Moisoi of the MRC Toxicology Unit at
the University of Leicester. These were bred in-house and
PINK1+/+, +/2 and 2/2 genotypes were generated. Genotyp-
ing was performed by extracting DNA from mouse ear biopsies
using a Qiagen DNeasy kit with a proteinase K and spin column
extraction method (Qiagen, UK) as previously described [3].
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Myocardial Infarction in PINK1 Knockout Mouse Hearts
Hearts from PINK1+/+, PINK1+/2 and PINK12/2 mice
(10–15 weeks, 20–30 g) were isolated and perfused using
a Langendorff constant pressure system as described previously
[1]. Mice were given 500 IU of heparin by intraperitoneal
injection before being culled by cervical dislocation. Hearts were
rapidly excised and retrogradely perfused via the aorta on
a Langendorff-apparatus (AD Instruments, UK) at 100 mmHg,
with oxygenated Krebs-Henseleit buffer containing NaCl
118 mM, NaHCO3 24 mM, KCl 4 mM, NaH2PO4 1 mM,
CaCl2 1.8 mM, MgCl2 1.2 mM and glucose 10 mM. Myocardial
temperature was maintained at 37.060.5uC. Isolated perfused
hearts were subjected to a 30 minute stabilization period followed
by 35 minute global normothermic ischemia and 30 minute
reperfusion. Infarct size was measured by perfusing a 1%
triphenyltetrazolium chloride (TTC) solution retrogradely through
the aorta and incubating the hearts at 37.0uC for 10 min before
storing at 220.0uC. Subsequently, hearts were sliced (,1 mm
slices), destained in formalin, photographed and planimetered
using the NIH Image 1.63 software package (National Institutes of
Health, Bethesda, MD, USA). Infarct size was calculated as the
percentage of the whole myocardium at risk (I/R%).
Isolation of Adult Murine Cardiomyocytes
As described previously [15] PINK1+/+ and PINK12/2 mice
(10–15 weeks, 20–30 g) were injected (i.p) with 500 IU of heparin
30 minutes prior to an 0.01 mg/g i.p injection of anaesthetic,
(10 mg/ml Ketamine, 2 mg/ml Xylazine and 0.06 mg/ml
Atropine) as a terminal procedure. Hearts were excised and
immediately placed in ice cold calcium free perfusion buffer
(113 mM NaCl, 4.7 mM KCL, 0.6 mM KH2PO4, 0.6 mM
Na2HPO4, 1.2 mM MgSO4.7H2O, 12 mM NaHCO3, 10 mM
KHCO3, 30 mM Taurine, 10 mM HEPES, 11 mM Glucose and
10 mM 2,3-Butanedione monoxime). Within 3 minutes the heart
was secured to a 22 gauge cannula via the aorta and attached to
a perfusion apparatus. The heart was retrogradely perfused at
3 ml/min, with pre-warmed (37.0uC) oxygenated (95%O2/
5%CO2) calcium-free perfusion buffer for 4 minutes. The heart
was then perfused for 10 minutes with pre-warmed oxygenated
digestion buffer (220 U/ml of type 2 Collagenase (Worthington,
UK) and 55 U/ml Hyaluronidase (Sigma, UK) dissolved in the
calcium free perfusion buffer and supplemented with 12.5 mM
CaCl2). The ventricles were collected in 10 mlof digestion buffer
and gently teased apart for additional tissue disruption. The tissue
was digested further by incubating the mixture with 95%O2/
5%CO2 in a shaking incubator (180 rpm) at 37uC for 10 minutes.
The supernatant was collected and the remaining tissue pellet was
incubated with an additional 10 ml digestion buffer followed by 10
minutes incubation with 95%O2/5%CO2 in a shaking incubator
at 37uC. Under sterile conditions each ventricular cell suspension
was transferred to a fresh tube and 5% FBS was added. The cells
were centrifuged at 600 relative centrifugal force (RCF) for 3
minutes to separate the larger, cardiomyocyte pellet. The smaller
fibroblasts and remaining connective tissue in the supernatant
were discarded. The cardiomyocyte pellet was re-suspended in
a low calcium buffer, which consisted of the calcium free perfusion
buffer supplemented with 12.5 mM CaCl2. Small volumes of
calcium were re-introduced to the cardiomyocyte suspension every
4 minutes to gradually reach a final concentration of 1 mM. The
cells were then centrifuged at 600 RCF for 3 min and re-
suspended in 1–2 ml of plating media (Medium-199)(Sigma, UK)
supplemented with 2 mg/ml bovine serum albumin, 0.66 mg/ml
creatine, 0.66 mg/ml taurine, 0.32 mg/ml carnitine, 50 U/ml
penicillin, 5 mg/ml streptomycin and 25 mM blebbistatin (Calbio-
chem, Nottingham, UK). The cell suspension was then added to
a glass cover slip, 22 mm diameter (VWR, Lutterworth, UK) pre-
coated with laminin (1 mg/ml) to aid cell adhesion. Cells were left
to adhere for 1 hr at 37uC, 95%O2/5%CO2 and 90% humidity.
Finally, each cover slip was washed with plating media and the
adhered cardiomyocytes were incubated with 1 ml of fresh plating
media without blebbistatin.
Measuring Mitochondrial Membrane Potential in
PINK12/2 Cardiomyocytes
Primary adult cardiomyocytes were isolated from the myocar-
dium of PINK1+/+ and 2/2 mice, as described above and
loaded with 50 nM TMRM diluted in imaging buffer (which
consisted of low calcium perfusion buffer without BDM and
supplemented with 10 mM HEPES and 1.2 mM CaCl2 at
pH 7.4) for 30 minutes. This was used to measure the
mitochondrial membrane potential [4,18]. The isolated cardio-
myocytes were mounted onto the confocal apparatus. The HeNe
laser (543 nm) used to excite the TMRM was set to 2% power to
prevent bleaching. Images were captured and the fluorescent
intensity of each cell was recorded using the Leica application suite
for Advanced Fluorescence (LAS AF Leica TCS SP5).
Measuring Oxygen Consumption in Intact
Cardiomyocytes and Isolated Mitochondria
To measure respiration rate in intact cells, approximately 26
106 cells were suspended in HBSS in a Clark-type oxygen
electrode thermostatically maintained at 37uC. The oxygen
electrode was calibrated with air-saturated water, assuming
406 nmol O atoms/ml at 37uC. Oxygen consumption was
measured over time with addition of oligomycin (final concentra-
tion 2 mg/ml) and 1 mM FCCP.
To measure respiratory control ratio, intact mitochondria were
isolated from hearts of WT and PINK1 KO mice by a method of
differential centrifugation [22] and resuspended in medium
containing 135 mM KCl, 10 mM NaCl, 20 mM HEPES,
0.5 mM KH2PO4, 1 mM MgCl2, 5 mM EGTA at pH 7.1.
Oxygen consumption was measured in a Clark-type oxygen
electrode thermostatically maintained at 25uC. Glutamate (5 mM)
and malate (5 mM) were added to measure Complex I-linked
respiration, succinate (5 mM) with rotenone (5 mM) were added to
measure Complex II-linked respiration.
All data were obtained using an Oxygraph Plus system with
Chart recording software.
Measuring Time to Contracture in PINK12/2
Cardiomyocytes
Primary adult cardiomyocytes were isolated from PINK1+/+
and 2/2 hearts, as described above, and, while imaging the cells,
10 mM carbonyl cyanide m-chlorophenyl hydrazone (CCCP) was
added to the imaging buffer. In the presence of this uncoupling
agent, the F0F1ATPase runs in ‘‘reverse’’ mode, consuming ATP
in order to pump protons out of the mitochondria and maintain
the membrane potential. When ATP decreases to a threshold
level, adult cardiomyocytes undergo rigor contracture.
The time to contracture can therefore be used as an indirect
measure of basal levels of ATP or the activity of F0F1ATPase [23–
25]. Sequential images of cells incubated with CCCP were taken
at intervals of one minute using a standard light microscope affixed
with a SPOT camera (Diagnostics Instruments, USA) connected
to SPOT imaging software version 4.6 (Diagnostic Instruments,
USA). The time to contracture was recorded and compared in the
isolated PINK1+/+ and 2/2 cardiomyocytes.
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Measuring ROS during SIRI in PINK12/2 Cardiomyocytes
The generation of ROS following SIRI was investigated in
isolated adult cardiomyocytes isolated from PINK1+/+ and
PINK12/2 mouse hearts. Cardiomyocytes were subjected to
45 min simulated ischemia followed by 30 min re-oxygenation
(SIRI) in the presence of 2 mM dihydroethidium (DHE, Molecular
Probes, Invitrogen, UK), which is oxidized in the presence of
superoxide to become fluorescent [26]. The fluorescence intensity,
reflecting ROS levels, using SPOT imaging software version 4.6
(Diagnostic Instruments, USA) and NIH-Image, values were
normalized to PINK1+/+ normoxic control.
Statistical Analysis
Values are mean 6 SEM. Data were analyzed using either the
Student’s t-test or one-way analysis of variance (ANOVA),
followed by Bonferroni’s multiple comparison post hoc test.
P,0.05 was considered significant.
Results
PINK1 Over-expression Protects HL-1 Cells against SIRI
PINK1 over-expression significantly reduced HL-1 cardiac cell
death following SIRI: 49.062.4% in the vector control to
29.065.2% with PINK1 (Figure 1; P,0.05). The proportion of
dead cells in the time-matched normoxic control conditions was
,5.0% and this was not significantly altered by transgene
expression.
PINK1 Over-expression in HL-1 Cells Decreases
Susceptibility to MPTP Opening
PINK1 over-expression in HL-1 cells delayed the time to MPTP
opening by 1.360.3 fold when compared to control values
(P,0.01; Figure 2). The delay in MPTP opening was similar to
that conferred by the known MPTP inhibitor, CsA (1.460.1
fold;P,0.05; Figure 2).
Myocardial Infarct Size is Increased in PINK1 Knockout
Mice
PINK12/2 mice developed significantly larger myocardial
infarcts following an episode of sustained ischemia-reperfusion
injury compared to PINK1+/+ mice, with PINK1+/2 mice
sustaining an intermediate sized infarct (25.162.0% in PINK1+/+
hearts versus 38.963.4% in PINK1+/2 hearts; P,0.01) and
(25.162.0% in PINK1+/+ hearts versus 51.564.3% in PINK12/
2 hearts (P,0.001)(see Figure 3).
Mitochondrial Membrane Potential and Time to
Contracture in PINK12/2 Cardiomyocytes
Since PINK1 has been implicated in mitochondrial function we
evaluated mitochondrial membrane potential in primary adult
cardiomyocytes under basal conditions. This was found to be lower
in PINK12/2 cardiomyocytes compared to PINK1+/+ cardio-
myocytes (Figure 4), as evidenced bydecreasedTMRMfluorescence
(In arbitrary units: 12.162.8 in PINK12/2 cardiomyocytes versus
17.962.6 in PINK1+/+ cardiomyocytes; P,0.05; Figure 5).
Oxygen Consumption in Isolated Intact Cardiomyocytes
The basal oxygen consumption rate was significantly reduced in
the PINK1 KO cardiomyocytes (0.4860.04 nmol/O2/min/10
6
cells, N= 4 experiments; Figure 6) compared to control cells
(0.8160.01 nmol O/min/106 cells, N= 4 experiments, P,0.001).
Oligomycin (2 mg/ml) inhibited the respiration coupled to oxidative
phosphorylation in control cells (to 0.1160.01 nmol O/min/106
cells, P,0.05) but significantly less in PINK1 KO cardiomyocytes
(0.3760.03 nmol O2/min/10
6 cells, compared to basal
0.4860.04 nmol/O2/min/10
6 cells; P,0.001; Figure 6). 1 mM
FCCPacceleratedrespiration tomaximal levels incontrol cells,but to
Figure 1. Over-expression of PINK1 in HL-1 cells significantly
reduced cell death following simulated ischemia-reperfusion
injury (SIRI) compared to Vector control. N=4 independent
experiments. *P,0.05.
doi:10.1371/journal.pone.0062400.g001
Figure 2. Over-expression of PINK1 in HL-1 cells significantly
delayed the time taken to induce MPTP opening compared to
vector control. Treatment with cyclosporin A (CsA), the known MPTP
inhibitor, also delayed the time taken to induce MPTP opening. Data are
normalized to control. N = 4 independent experiments. *P,0.05.
doi:10.1371/journal.pone.0062400.g002
Figure 3. Effect of PINK1 ablation on myocardial infarct size
expressed as a percentage of the area at risk (I/R%) in isolated
perfused murine hearts. Compared to WT litter-mate control hearts,
PINK12/2 hearts sustained significantly larger myocardial infarct sizes.
PINK1+/2 hearts sustained myocardial infarct sizes which were larger
than WT littermate control hearts but smaller than PINK12/2 hearts.
N = 6 per group.*P,0.01 and **P,0.001 compared to PINK1+/+ hearts.
doi:10.1371/journal.pone.0062400.g003
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a lesser extent in PINK1 KO cardiomyocytes (4.260.19 vs.
3.460.03 nmol/O2/min/10
6 cells; P,0.001; Figure 6). This data
suggest a generalised impairment of respiration in PINK1KOheart
cells. To identify themechanism underlying the impairedmitochon-
drial respiration we investigated isolated mitochondria.
Oxygen Consumption in Isolated Mitochondria
We evaluated the effect of PINK1 deficiency on oxygen
consumption in isolated mitochondria. Compared to WT, oxygen
consumption in PINK1 deficient mitochondria in the presence of
the substrate of Complex I (5 mM Malate/5 mM Glutamate) was
not significantly different (N= 6 experiments; Figure 7a,c). Appli-
cation of Complex II substrate (succinate in the presence of
rotenone; N=6 experiments; Figure 7b,c) activated oxygen
consumption equally in PINK1-KO and WT heart mitochondria.
The respiratory control ratio (RCR), the ratio of state 3 (ADP-
stimulated) to state 4 respiration (no ADP present), is an indication
of the degree of coupling of the mitochondrial respiratory chain
activity to oxidative phosphorylation. The RCR was unchanged in
PINK1 KO, when compared to WT mitochondria.
Figure 4. The effect of PINK1 deficiency on TMRM fluorescence in adult cardiomyocytes. Representative fluorescent images of adult
murine cardiomyocytes isolated from i) PINK1+/+ mice and ii) PINK12/2 mice demonstrating a lower mitochondrial membrane potential (decreased
TMRM fluorescence) in PINK12/2 cardiomyocytes. N = 5 independent experiments.*P,0.05.
doi:10.1371/journal.pone.0062400.g004
Figure 5. The effect of PINK1 deficiency on mitochondrial
membrane potential. Mitochondrial resting membrane potential
measured by TMRM fluorescence (in arbitrary units A.U.) in PINK1+/+
and PINK12/2 adult cardiomyocytes, demonstrating a lower mito-
chondrial membrane potential (decreased TMRM fluorescence) in
PINK12/2 cardiomyocytes. N = 5 independent experiments.*P,0.05.
doi:10.1371/journal.pone.0062400.g005
Figure 6. Oxygen consumption in intact cardiomyocytes
isolated from WT and PINK1 KO mice under basal conditions
and in response to oligomycin (2 mg/ml) and the uncoupler,
FCCP (1 mM).
doi:10.1371/journal.pone.0062400.g006
Figure 7. Oxygen consumption in isolated mitochondria
isolated from WT and PINK1 KO mice. in the presence of the (a)
Complex I substrate (5 mM Malate/5 mM Glutamate) (b) Complex II
substrate (succinate in the presence of rotenone) (c) The respiratory
control ratio (RCR), the ratio of state 3 (ADP-stimulated) to state 4
respiration (no ADP present), which is an indication of the degree of
coupling of the mitochondrial respiratory chain activity to oxidative
phosphorylation.
doi:10.1371/journal.pone.0062400.g007
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Time to Uncoupler-induced Hypercontracture
The time taken to hypercontracture following the administra-
tion of mitochondrial uncoupler, CCCP was recorded in
cardiomyocytes. This time was significantly decreased in
PINK12/2 cardiomyocytes (22.861.8 min in PINK1+/+ cells
to 13.361.6 min in PINK12/2 cells; P,0.01; Figure 7) in-
dicating either a significantly lower basal level of cellular ATP or
decreased function of the F0F1ATPase. However, it must be
important to bear in mind that this is an indirect measure of
cellular ATP levels.
Oxidative Stress Post-SIRI is Increased in PINK12/2 Mice
At baseline, there was no significant difference in oxidative stress
in isolated PINK1+/+ and PINK12/2 cardiomyocytes (Figure 8).
However, following SIRI, the PINK12/2 cardiomyocytes
exhibited a significantly greater level of superoxide production
when compared to PINK1+/+ cardiomyocytes (145612% in
PINK1+/+ cardiomyocytes compared to 216627% in PINK12/
2 cardiomyocytes following SIRI (P,0.05; Figure 9).
Discussion
The major findings of the current study are as follows: (1) Over-
expressing PINK1 in the HL-1 cardiac cell line delayed the time
taken to induce MPTP opening and reduced cell death following
SIRI; (2) Mice lacking PINK1 sustained larger myocardial infarcts
compared to wild type littermates (PINK1+/+), suggesting that the
absence of PINK1 in the heart makes it more vulnerable to IRI.
Interestingly, mice heterozygous for PINK1 sustained myocardial
infarcts which were intermediate in size; (3) The increased
susceptibility to IRI of PINK12/2 mice may be due to impaired
mitochondrial function, as evidenced by a lower mitochondrial
potential under basal conditions, impaired mitochondrial respira-
tion, increased susceptibility to rigor contracture, and enhanced
oxidative stress production during SIRI.
Figure 8. Time taken to induce contracture following administration of the uncoupler, CCCP (10 mM) in PINK1+/+ and PINK12/2
adult cardiomyocytes. N=5 independent experiments.*P,0.01.
doi:10.1371/journal.pone.0062400.g008
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Our study suggests a role for mitochondrial PINK1 as a target
for cardioprotection in the heart. This mitochondrial protein
appears to be required for endogenous protection against SIRI, as
its genetic ablation resulted in an enhanced susceptibility to
myocardial infarction, a response which was graded according to
whether one or both PINK1 alleles were knocked-out. Our data
suggests that the loss of PINK1 increases the heart’s vulnerability
to ischemia-reperfusion injury by worsening mitochondrial func-
tion. Its absence was associated with mitochondrial membrane
depolarization, impaired mitochondrial respiration, increased
susceptibility to rigor contracture, and more oxidative stress
production during SIRI. In contrast, the over-expression of
PINK1 was able to prevent the opening of the MPTP in the
HL-1 cardiac cell line. A minor limitation of our study is that we
did not investigate whether MPTP opening susceptibility was
increased in adult cardiomyocytes deficient in PINK1. A recently
published experimental study has also reported detrimental effects
on mitochondrial function and cardiomyocyte homeostasis in mice
lacking PINK1, but the effects of PINK1 on susceptibility to IRI
was not explored in that study [27]. Furthermore, these authors
reported cardiac hypertrophy and cardiac fibrosis from 2 months
of age [27]. Despite many studies implicating PINK1 as
a neuroprotective mitochondrial protein kinase, there have been
a limited number of studies investigating the protective effect of
PINK1 against ischemic neuronal injury. Shan and co-workers
[28] have reported that PINK1 can protect neonatal rat cortical
neurons against simulated ischemia.
Emerging studies have suggested that a functional impairment in
activity of complex I of the electron transport chain underlies the
mitochondrial dysfunction central to Parkinson’s disease [4,29].The
involvement of complex I inhibition in the pathogenesis of
Parkinson’s disease has long been appreciatedwith reduced complex
Iactivitynoted inpatientswithParkinson’sdisease[30],andtheuseof
complex I inhibitors such as rotenone to reproduce robust animal
models of Parkinson’s disease [31]. Complex I inhibition may also
explain some of the other known features of Parkinson’s mitochon-
drial dysfunction includingmitochondrialmembranedepolarization
[3,4,29], increase production of oxidative stress from complex I
[3,4,6–9], reducedmitochondrial respiration andATPdepletion [5]
and predisposition toMPTP opening [4].
Interestingly, in our studies, we found that in isolated PINK1
deficient mitochondria there were no changes in the rate of
mitochondrial respiration in the presence of substrates for
Complex I and Complex II. Furthermore, PINK1 deficiency
had no effect on uncoupling of oxidative phosphorylation as the
respiratory control ratio remained unchanged. These findings are
in agreement with experimental data, which have been performed
in other cell types [4,32]. However, in intact cardiomyocytes,
PINK1 deficiency did significantly depress oxygen consumption,
suggesting that the absence of PINK1 does not impair respiratory
complex function but affects the delivery of substrates to the
mitochondria (such as inhibition of glycolysis or the TCA cycle or
inhibition of glucose uptake) [4].
The MPTP is a non-selective high-conductance channel of the
innermitochondrialmembranewhoseopeningresults incelldeathby
uncoupling oxidative phosphorylation [20,33,34]. In the absence of
PINK1,anumberof factors canresult inan increased susceptibility to
MPTP opening including mitochondrial membrane depolarization
[29], reduced mitochondrial calcium retention [4], increased
oxidative stress [3,4,6–9]particularly fromcomplex I inhibition [35].
Of course there may be other beneficial effects on mitochondrial
function which may explain the cardioprotective effects of PINK1.
PINK1 has been reported to phosphorylate TNF receptor-
associated protein 1 (TRAP1), a mitochondrial chaperone protein,
which protects against oxidative stress-induced apoptotic cell death
[36]. It has been proposed that PINK1 promotes the translocation
of Parkin (an E3 ubiquitin ligase) to dysfunctional mitochondria,
where outer mitochondrial membrane Mitofusins are ubiquinated,
to provide a signal for mitophagy (the autophagic removal of
dysfunctional mitochondria) [37,38]. Changes in mitochondrial
morphology can impact on a variety of cellular functions including
metabolism, development and more recently cardioprotection
[39]. However, the effect of PINK1 on mitochondrial morphology
has been variable and inconclusive [40]. Whether any of these
other effects of PINK1 on mitochondrial function occur in the
heart remains to be determined.
Conclusions
In conclusion, our data suggests that the loss of PINK1 increases
the heart’s vulnerability to ischemia-reperfusion injury, which may
be due, in part, to worsened mitochondrial function. The
mechanism underlying its cardioprotective effect appears to be
mediated at the level of the mitochondria with improved
mitochondrial function, less oxidative stress, and reduced suscep-
tibility to MPTP opening. Therefore, the discovery of novel
pharmacological activators of PINK1 may provide a novel
therapeutic strategy for cardioprotection. Furthermore, its impor-
tance for endogenous cardioprotection lends further support to the
importance of mitochondria in cardioprotection.
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Figure 9. Cardiomyocytes isolated from PINK12/2mice exhibit
similar amounts of oxidative stress at baseline, but exhibit
significantly greater amounts of oxidative stress following
simulated ischemia-reperfusion injury (SIRI) when compared
to cardiomyocytes isolated from PINK1+/+ mice. N=4 hearts per
group.*P,0.05 compared to PINK1+/+ at baseline. **P,0.05 compared
to PINK12/2 following SIRI.
doi:10.1371/journal.pone.0062400.g009
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